First volunteers dosed in Phase I clinical trial of PBT434, Prana’s lead therapy for parkinsonian diseases July 3, 2018August 16, 2022
Prana Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression: MGH team publishes data that supports the use of PBT2 in Huntington disease July 17, 2013August 16, 2022
Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial February 18, 2014August 16, 2022
